Social Media Policy
Prometheus Laboratories (“Prometheus”, “we”, “us” or “our”) recognizes the benefits of social media like blogs, wikis, social networks (e.g., Facebook, YouTube, LinkedIn, etc.) and welcomes its use as a way of communicating, interacting and doing business. Social media’s high speed, level of interactivity and global access to information we or you publish merits particular consideration to the appropriate uses for these applications. Prometheus has the responsibility to effectively manage the company’s reputation online and to selectively engage and participate in the online conversations that mention us every day. You should not construe our lack of participation in an online conversation as an endorsement by us of the views expressed therein, or any warranty or guarantee of any strategy, recommendation, treatment, action, or application of medication or preparation made by the author of the content.
We reserve the right to delete, hide, or restrict content, in whole or in part, submitted to social media networks that it, in its sole discretion, deems abusive, threatening, defamatory, obscene, in violation of intellectual property, privacy, or other proprietary rights, in violation of our Terms and Conditions of Use or for any other reason.
PROMETHEUS, Anser, FIBROSpect, IBD sgi Diagnostic, LactoTYPE, Monitr and RiskImmune are trademarks or registered trademarks of Prometheus Laboratories Inc, San Diego, California and are protected by U.S and international trademark and copyright laws. All other trademarks or service marks are the property of their respective owners and believed to be accurate, but not guaranteed to be so.
No license to use any of our trademarks is given or implied. Users are not permitted to use these trademarks without the prior written consent of Prometheus Laboratories. The use of these trademarks or any other materials, except as permitted herein, is expressly prohibited and may be in violation of applicable law.
California Transparency in Supply Chain Notice
To ensure compliance with the California Transparency in Supply Chain Notice (SB 657, California Civil Code section 1714.43), under no circumstances is it acceptable for child, forced or trafficked labor to be used in the production of any of our raw materials, components, or end products.
We respect the human rights of workers within its direct supply chain. Our efforts in this area include: the use of contract provisions with our direct suppliers requiring their compliance with applicable labor laws and barring those suppliers from the use of child, slave or forced labor; audits of suppliers to evaluate supplier compliance with labor laws for trafficking and slavery in supply chains; requesting that new direct suppliers certify their compliance with applicable labor laws including that they do not use child, slave or forced labor; and training to employees working with direct suppliers to bring attention to this law and the issue of human trafficking and slavery specifically for mitigating risks within the supply chains of products.
Supply Chain and Conflict-Free Minerals
We respect the human rights of workers within its direct supply chain by supporting the goal of avoiding the use of conflict minerals that directly or indirectly benefit armed groups in the Democratic Republic of Congo (DRC) or adjoining countries.
The EICC Code of Conduct includes a provision related to the responsible sourcing of minerals and requires suppliers to have a policy to reasonably assure that the tantalum, tin, tungsten, and gold in the products they manufacture does not directly or indirectly finance or benefit armed groups that are perpetrators of serious human rights abuses in the DRC or an adjoining country. All suppliers shall commit to the Electronic Industry Citizenship Coalition (EICC) Code of Conduct by establishing their own due diligence program to ensure supply chains that are free of conflicts minerals and to make their due diligence measures available to Prometheus upon request.
Effective March 2019